NASDAQ: MGTX
Meiragtx Holdings PLC Stock

$7.09+0.19 (+2.75%)
Updated Apr 30, 2025
MGTX Price
$7.09
Fair Value Price
N/A
Market Cap
$559.08M
52 Week Low
$3.85
52 Week High
$8.75
P/E
-3.34x
P/B
8.24x
P/S
12.78x
PEG
N/A
Dividend Yield
N/A
Revenue
$33.28M
Earnings
-$147.79M
Gross Margin
28.5%
Operating Margin
-404.22%
Profit Margin
-444.1%
Debt to Equity
2.98
Operating Cash Flow
-$104M
Beta
1.21
Next Earnings
May 7, 2025
Ex-Dividend
N/A
Next Dividend
N/A

MGTX Overview

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine MGTX's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
MGTX
Ranked
#60 of 462

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important MGTX news, forecast changes, insider trades & much more!

MGTX News

Overview

Due Diligence Score

Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MGTX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MGTX is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MGTX is poor value based on its book value relative to its share price (8.24x), compared to the US Biotechnology industry average (4.45x)
P/B vs Industry Valuation
MGTX is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more MGTX due diligence checks available for Premium users.

Valuation

MGTX fair value

Fair Value of MGTX stock based on Discounted Cash Flow (DCF)

Price
$7.09
Fair Value
-$5.82
Undervalued by
221.84%
MGTX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

MGTX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-3.34x
Industry
-162.28x
Market
29.18x

MGTX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
8.24x
Industry
4.45x
MGTX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MGTX's financial health

Profit margin

Revenue
$21.4M
Net Income
-$39.4M
Profit Margin
-184.2%
MGTX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
MGTX's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$269.8M
Liabilities
$201.9M
Debt to equity
2.98
MGTX's short-term assets ($123.52M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MGTX's long-term liabilities ($141.14M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MGTX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MGTX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$23.3M
Investing
-$1.2M
Financing
$4.2M
MGTX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

MGTX vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
MGTXC$559.08M+2.75%-3.34x8.24x
FTREC$560.70M-1.58%-1.70x0.41x
RLAYC$564.51M+7.42%-1.41x0.73x
SVRAD$552.43M-1.84%-6.67x3.22x
AKBAC$569.32M-0.82%-7.30x-11.58x

Meiragtx Holdings Stock FAQ

What is Meiragtx Holdings's quote symbol?

(NASDAQ: MGTX) Meiragtx Holdings trades on the NASDAQ under the ticker symbol MGTX. Meiragtx Holdings stock quotes can also be displayed as NASDAQ: MGTX.

If you're new to stock investing, here's how to buy Meiragtx Holdings stock.

What is the 52 week high and low for Meiragtx Holdings (NASDAQ: MGTX)?

(NASDAQ: MGTX) Meiragtx Holdings's 52-week high was $8.75, and its 52-week low was $3.85. It is currently -18.97% from its 52-week high and 84.16% from its 52-week low.

How much is Meiragtx Holdings stock worth today?

(NASDAQ: MGTX) Meiragtx Holdings currently has 78,854,936 outstanding shares. With Meiragtx Holdings stock trading at $7.09 per share, the total value of Meiragtx Holdings stock (market capitalization) is $559.08M.

Meiragtx Holdings stock was originally listed at a price of $15.00 in Jun 8, 2018. If you had invested in Meiragtx Holdings stock at $15.00, your return over the last 6 years would have been -52.73%, for an annualized return of -11.74% (not including any dividends or dividend reinvestments).

How much is Meiragtx Holdings's stock price per share?

(NASDAQ: MGTX) Meiragtx Holdings stock price per share is $7.09 today (as of Apr 30, 2025).

What is Meiragtx Holdings's Market Cap?

(NASDAQ: MGTX) Meiragtx Holdings's market cap is $559.08M, as of May 2, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Meiragtx Holdings's market cap is calculated by multiplying MGTX's current stock price of $7.09 by MGTX's total outstanding shares of 78,854,936.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.